Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
M

MMSI

Nasdaq

MERIT MEDICAL SYSTEMS INC

Latest disclosureSeptember 9, 2026
Insider score Why 31?
31/ 100
Qualifying buys · 30d
$0

5 purchases · 3 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 25

Limited filing history
All25Buying5Selling3Other17
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

5 of 25 trades · May 5, 2026 – September 4, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.
Purchase disclosed

Christian Adam Smith

Chief Commercial Officer

Common Stock, No Par Value

Reported value
$99.19K
Reported price
$61.00 / share
Traded May 11, 2026Filed May 13, 2026SEC filing
Purchase disclosed

Brian G. Lloyd

CHIEF LEGAL OFFICER, SECRETARY

Common Stock, No Par Value

Reported value
$125.25K
Reported price
$62.625 / share
Traded May 7, 2026Filed May 11, 2026SEC filing
Purchase disclosed

Martha Goldberg Aronson

President and CEO

Common Stock, No Par Value

Reported value
$120.88K
Reported price
$60.44 / share
Traded May 6, 2026Filed May 7, 2026SEC filing
Purchase disclosed

Raul Parra Jr.

CFO AND TREASURER

Common Stock, No Par Value

Reported value
$91.52K
Reported price
$61.01 / share
Traded May 6, 2026Filed May 7, 2026SEC filing
Purchase disclosed

Michel J. Voigt

CHIEF HUMAN RESOURCES OFFICER

Common Stock, No Par Value

Reported value
$136.46K
Reported price
$60.65 / share
Traded May 5, 2026Filed May 7, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Chief Commercial OfficerCommon Stock, No Par ValuePurchase1,626$61.00 / share$99.19KMay 11Filed May 13 · 2d laterSEC filing
CHIEF LEGAL OFFICER, SECRETARYCommon Stock, No Par ValuePurchase2,000$62.63 / share$125.25KMay 7Filed May 11 · 4d laterSEC filing
President and CEOCommon Stock, No Par ValuePurchase2,000$60.44 / share$120.88KMay 6Filed May 7 · 1d laterSEC filing
CFO AND TREASURERCommon Stock, No Par ValuePurchase1,500$61.01 / share$91.52KMay 6Filed May 7 · 1d laterSEC filing
CHIEF HUMAN RESOURCES OFFICERCommon Stock, No Par ValuePurchase2,250$60.65 / share$136.46KMay 5Filed May 7 · 2d laterSEC filing

Congress transactions 1

All Congress filings
Sale disclosed

Merit Medical Systems, Inc. - Common Stock (MMSI) · Stock

The filing reports a sale for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 25, 2025
Filed October 22, 2025 · 27d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

Qualifying common-equity purchase value

$143,323 of common-equity purchase value after transaction-age decay across 180 days.

+12 pts

Distinct buying groups

5 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+9 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+4 pts

CFO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+3 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+3 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0000856982
Latest public acceptance
Sep 9, 2026, 07:58 PM UTC
Score calculated
Oct 8, 2026, 03:51 PM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.